Mainz Biomed (MYNZ) said Friday it is implementing a one-for-40 reverse stock split of its common stock, effective Dec. 3, following the board's decision on Nov. 20.
No fractional shares will be issued. Instead, Mainz Biomed will pay cash depending on the value of the fractional shares, the company said.
The company's shares were down more than 12% in recent premarket trading.
Price: 0.22, Change: -0.032, Percent Change: -12.50